Biological High-Risk Paradigm and Platelet MAO Activity in Community Samples

Author(s):  
M. S. Buchsbaum ◽  
R. D. Coursey
1996 ◽  
Vol 94 (2) ◽  
pp. 105-111 ◽  
Author(s):  
P. O. Alm ◽  
B. Klinteberg ◽  
K. Humble ◽  
J. Leppert ◽  
S. Sörensen ◽  
...  

1990 ◽  
Vol 33 (3) ◽  
pp. 221-227 ◽  
Author(s):  
Christopher Reist ◽  
Richard J. Haier ◽  
Edward DeMet ◽  
Aleksandra Chicz-DeMet

1989 ◽  
Vol 19 (1) ◽  
pp. 79-90 ◽  
Author(s):  
Joanne Boyd Irving ◽  
Robert D. Coursey ◽  
Monte S. Buchsbaum ◽  
Dennis L. Murphy

SynopsisThe present study, using a diathesis-stress model, attempted to confirm prior findings with platelet monoamine oxidase (MAO) activity and stress in a middle-aged, non-clinic population. One hundred and seventy-eight adult males from a statewide community club were tested for platelet MAO activity and stressful life events and were also given a variety of psychological measures of both psychopathology and psychosocial coping. The data were examined both for correlations across the total sample and for a comparison of high-risk groups (top and bottom 15% of MAO activity) with a middle MAO group. Low platelet MAO activity was related to a higher incidence of contact with mental health professionals, and more frequent use of alcohol and cigarette smoking. High MAO activity was related to higher levels of anxiety and somatization. High levels of stress were related to increased psychosocial problems reported for female and family members, higher scores on two schizophrenia-related MMPI scales (schizophrenia and paranoia subscales), but fewer idiosyncratic associations, elevated hypomanic, depression, and anxiety scores, increased alcohol use, and increased use of prescribed antianxiety and sedative medication. Neither MAO nor stress were related to current levels of psychosocial coping. Moreover, no interaction effects were uncovered for MAO activity and stress combined.


1985 ◽  
Vol 147 (6) ◽  
pp. 730-731 ◽  
Author(s):  
E. G. Th. M. Hartong ◽  
J. G. Goekoop ◽  
E. J. M. Pennings ◽  
G. M. J. van Kempen

1981 ◽  
Vol 139 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Frank Owen ◽  
Rachel C. Bourne ◽  
Timothy J. Crow ◽  
Eve C. Johnstone ◽  
Adnam A. Fadhli

SummaryPlatelet MAO activity was assessed in 35 schizophrenics during a trial of the isomers of flupenthixol. Enzyme activity was unrelated to severity of symptoms, the presence of delusions, hallucinations or thought disorder or to negative symptoms. In a few patients MAO activity fluctuated widely with time, but in the group of patients on medication there was a slow decrease in enzyme activity which was significant after 28 days of treatment. Enzyme activity after 14 days' drug treatment was still correlated with activity before treatment, but after 28 days this significant correlation disappeared. Slow effects of neuroleptic drugs on platelet MAO activity may explain previous findings of reduced activity of the enzyme in schizophrenia.


1998 ◽  
Vol 32 (1) ◽  
pp. 49-54 ◽  
Author(s):  
C.K. Farren ◽  
A.W. Clare ◽  
K.F. Tipton ◽  
T.G. Dinan

1987 ◽  
Vol 75 (5) ◽  
pp. 456-463 ◽  
Author(s):  
M. F. Poirier ◽  
H. Lôo ◽  
N. Mitrani ◽  
C. Benkelfat ◽  
S. Askienazy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document